Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

This publication has 40 references indexed in Scilit:

• Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes
  Published by Elsevier ,2003
• MANAGEMENT OF A POSITIVE SURGICAL MARGIN AFTER RADICAL PROSTATECTOMY: DECISION ANALYSIS
  Journal of Urology, 2000
• Early Results of LH-RH Agonist Treatment with or without Chlormadinone Acetate for Hormone Therapy of Naive Localized or Locally Advanced Prostate Cancer: A Prospective and Randomized Study
  Japanese Journal of Clinical Oncology, 2000
• Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
  New England Journal of Medicine, 1999
• Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns
  Urology, 1999
• Natural History of Progression After PSA Elevation Following Radical Prostatectomy
  JAMA, 1999
• USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER: DATA FROM THE caPSURE DATABASE
  Journal of Urology, 1998
• Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial
  British Journal of Urology, 1997
• Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate-specific antigen and surgical margins
  Urology, 1996
• Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases
  Urology, 1994